Mantle cell lymphoma represent a clinicopathologically distinct entity of malignant non-Hodgkin's lymphoma (NHL) and are characterized by a specific chromosomal translocation t(11;14)(q13;q32) involving the cyclin D1 gene also designated as bcl-1/PRAD1 gene on chromosome 11 and the heavy chain immunoglobulin joining region on chromosome 14. We have established a PCR method to amplify t(11;14) junctional sequences in DNA from fresh frozen and paraffin-embedded tissue by bcl-1-specific primers in combination with a consensus immunoglobulin J H primer. A total of 65 cases histologically classified as mantle cell lymphoma (MCL) were analyzed for the presence of a t(11;14) translocation and monoclonal IgH-CDR3 rearrangements. From 26 patients with classical MCL and three cases with the anaplastic variant of MCL fresh frozen biopsy material was available for DNA extraction. We detected a bcl-1/J H rearrangement in 12 out of 29 samples (41%). In 36 cases paraffin-embedded lymph node tissue was the only source of DNA. In this material we found a bcl-1/J H rearrangement in six out of 31 samples with intact DNA (20%). To confirm the specificity of the PCR and to determine the bcl-1/J H junctional region sequences as clone-specific marker in individual patients we characterized the junctional DNA sequences by direct PCR sequencing in 16 cases. Interestingly we found that six bcl-1/J H junctions harbored D H segments in their N regions indicating that bcl-1/J H rearrangements can occur in a later stage of B cell ontogeny during which the complete V H to D H -J H joining or V H -replacement takes place. To investigate the suitability of IgH-CDR3 as sensitive molecular marker for those MCL patients in which a t(11;14) translocation can not easily be amplified, we additionally analysed 60 cases for the presence of monoclonally rearranged IgH genes by IgH-CDR3-PCR. A monoclonal IgH-CDR3 PCR product could be identified in 24 out of 29 fresh frozen samples (79%) whereas only 11 out of 31 samples (36%) with paraffin-derived DNA were positive. We demonstrate that automated fluorescence detection of monoclonal IgH-CDR3 PCR products allows the rapid and sensitive monitoring of minimal residual disease also in cases that lack a PCR amplifiable t(11;14) translocation. In combination with allele-specific primers the procedure may improve current experimental approaches for detection of occult MCL cells at initial staging and residual disease during and after therapy.
Introduction
Mantle cell lymphoma (MCL) has recently emerged as a distinct clinicopathologic entity among low-grade non-Hodgkin's lymphoma with characteristic molecular features. By cytogenetic investigations and Southern blotting a specific t (11;14) translocation can be detected in 60-70% of patients with MCL lymphoma. 1 This molecular alteration is characterized by the juxtaposition of the bcl-1 gene complex on chromosome 11 into the joining region of the immunoglobulin heavy chain gene on chromosome 14 . Approximately 30-50% of the breakpoints cluster in a 80-100 base pair region on chromosome 11 termed major translocation cluster (MTC). Associated with the translocation is the overexpression of cyclin D1 gene, a G1 cyclin involved in cell cycle regulation at the G1 to S phase transition. [2] [3] [4] [5] The clustering of breakpoints on chromosome 11 and the involvement of one of the six J H elements on chromosome 14 allows the amplification of t (11;14) translocation by PCR. 4, 6 Current diagnosis of MCL is based on morphological characteristics with a typical growth pattern and a specific immunophenotype with coexpression of CD5/CD20 antigens, lack of CD23 expression and rather specific expression of cyclin D1. 7 Nevertheless the distinction from other NHL entities, for example atypical CLL or follicular lymphoma, and the classification of MCL into existing schemes is sometimes difficult. The frequent molecular and cytogenetic detection of t (11;14) has improved the diagnostic accuracy not only in critical cases of MCL but may also provide a sensitive tool in the search for a molecular marker of occult lymphoma cells. [8] [9] [10] MCL are characterized by an advanced stage of disease at presentation and the prognosis is generally poor with a median survival of 43 months. 7 MCL appears incurable with conventional therapy, 7, 8 so new therapeutic strategies including myeloablative radiochemotherapy with autologous stem cell support are currently being investigated. [10] [11] [12] [13] Previous reports on high-dose therapy followed by autologous stem cell transplantation in patients with follicular lymphoma have shown a strong correlation between the presence or absence of PCR-detectable contaminating lymphoma cells in the reinfused stem cell products and long-term survival. 14 Recent reports in patients with MCL undergoing highdose chemotherapy and autologous bone marrow transplantation underline the importance of contaminating lymphoma cells in the autologous graft for the probability of relapse in these patients. 10 Therefore, the molecular monitoring of minimal residual disease (MRD) during and after therapy with high-dose or conventional therapy regimen seems essential for a better definition of the remission status and prognostic estimation of MRD in patients with MCL.
Hence we developed a reliable and effective PCR assay for the routine amplification of MTC bcl-1 gene rearrangements to define the optimal strategy for clonality assessment in MCL using either formalin-fixed, paraffin-embedded tissue or fresh frozen material as the source of DNA. In addition we investigated the suitability of an IgH-CDR3 PCR assay for those MCL patients where a t(11;14) translocation can not be amplified by routine PCR.
Materials and methods

Patients
A total of 65 newly diagnosed patients with mantle cell lymphoma (MCL) were selected for this study. The lymphomas were categorized according to the updated Kiel 15 and the REAL 9 classification, using conventional morphological and immunohistological techniques. Twenty-nine samples were collected from fresh frozen bone marrow or peripheral blood from patients admitted to the Department of Internal Medicine of the University of Gö ttingen between October 1987 and June 1995 (Table 1 ). The second group of samples was collected from 36 patients treated within a prospective ran- domized study of the German Low-Grade Lymphoma Study group comparing cyclophosphamide, vincristine, prednisone (COP) vs prednimustine, mitoxantrone (PmM) for initial cytoreduction followed by a second randomization for interferon alpha maintenance vs observation only. 16 The DNA samples of these patients were extracted from formalin-fixed paraffinembedded lymph node biopsies which were centrally collected for review and confirmed by two of us (RP and MT) as MCL at the Institute of Hematopathology (Deutsches Lymphknotenregister) in Kiel, Germany.
DNA preparation
High molecular weight DNA was extracted using an automated DNA extractor (model 341; Applied Biosystems (ABI), Weiterstadt, Germany) from snap-frozen peripheral blood or bone marrow specimens that were collected during routine diagnostic procedures in 29 cases (Table 1 ). In 36 cases DNA was extracted from paraffin-embedded lymph node biopsy specimens as described. 17 
t(11;14) PCR:
For PCR detection of t(11;14) translocations a seminested procedure was performed with an 18 mer external and an internal bcl-1 primer together with an 22 mer J H consensus primer. All nucleotides were prepared on a LKB Gene Assembler Plus DNA synthesizer (Pharmacia) by phosphoramidite chemistry. The J H consensus primer sequence was adopted from McCarthy et al. 18 For the design of bcl-1 primers the published bcl-1/MTC region sequence was used. 6 The sequences of the t(11;14) primers were:
PCR conditions: 0.5-1 g of sample DNA were used in a final volume of 50 l PCR buffer containing 3 mmol MgCl 2 , 40 M of each deoxynucleotide, 5 pmol of each primer and 2 units of AmpliTaq DNA Polymerase (Perkin-Elmer) for 30 cycles starting with bcl-1 primers G or F and J H primer in the first round followed by primer combination B and J H in the second round. Cycle conditions were: first denaturation 94°C for 7 min, in the following cycles 94°C 1 min, annealing 60°C for 30 s, no additional extension time for 30 cycles to reduce unspecific background. The first and second round had the same cycle conditions. As positive control, we used DNA extracted from the cell line JVM-2, a prolymphocytic leukemia cell line bearing a t(11;14) translocation.
IgH-CDR3-PCR
The PCR primers and cycling conditions followed the recently described protocol. 19 Briefly, IgH-CDR3 amplification reactions with consensus V H and J H primers were performed in an automated thermocycler (model 480, Perkin Elmer) with 0.5-1.0 g of sample DNA in a final volume of 30 l reaction buffer containing 40 M of each deoxynucleotide, 5 pmol of each primer and 2 units of U1Tma DNA Polymerase (PerkinElmer, Weiterstadt, Germany) for 35 cycles with primers V H and J H . 19 Cycle conditions were: denaturation at 96°C for 1 min with annealing/extension at 55°C for 45 s). Hot startinitiated PCR was performed by addition of BioWax (Biozym, Hameln, Germany) to the reaction tubes. The V H primer was HPLC-purified and labeled at its 5Ј end with 6-FAM (6-carboxyfluorescein) (ABI) generating blue fluorescence signals after excitation with an argon ion laser in the automated sequencer (model 373A, ABI).
Fluorescent fragment analysis (gene scanning)
For automated fluorescent fragment analysis, aliquots of the PCR products (1-2 l) were mixed with equal amounts of loading buffer (5 volumes formamide:1 volume EDTA; 10% dextran blue) and 0.5 l of the internal size standard Genescan-350-ROX (ABI). After denaturation for 3 min at 95°C products were analyzed by automatic fluorescence quantification and size determination using the computer program Genescan 672 (ABI) as described in detail in Ref. 27 . Typical running times were 2-3 h with a 12 cm long electrophoresis gel.
Direct DNA sequencing
All PCR products which showed a band in the expected size range of t(11;14) PCR were sequenced to determine the respective chromosome 11 and chromosome 14 breakpoints and the patient-specific N-region and to avoid false positive PCR results which is rather common especially in seminested PCR procedures. For direct sequencing, PCR products were diluted 1:100 in autoclaved H 2 O. 2 l of the dilution mixture were reamplified with either the internal bcl-1 primer B or the consensus J H primer in 30 l reaction buffer (see IgH-CDR3 PCR) for 30 cycles (cycle conditions: initial denaturation at 96°C for 7 min followed by 15 cycles with denaturation at 96°C for 1 min, annealing at 58°C for 1 min and extension at 73°C for 2 min followed by 15 additional cycles with denaturation at 96°C for 1 min, annealing at 55°C for 1 min and extension at 73°C for 2 min). The products were purified before sequencing by differential precipitation of DNA. 19 Five to 8.5 l of the purified PCR product were subjected to a fluorescent dye terminator cycle sequencing reaction (kit purchased from ABI) with either 10 pmol T7 (ABI) or RSP (reverse sequencing primer; Pharmacia LKB, Freiburg, Germany). Sequencing reaction products were analyzed on the DNA sequencer with the SeqEd 672 DNA Sequence Editor (ABI). J H elements were identified by comparison with published germline sequences. 20, 21 Individual D H segments were identified by comparison with 32 published germline D H DNA sequences.
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Results
A total of 65 patients with histologically confirmed mantle cell lymphoma (MCL) were investigated in this study for the presence of t(11;14) translocations and IgH-CDR3 rearrangements.
t(11;14) PCR results
From 26 patients with classical MCL and three cases with the anaplastic variant of MCL material was available for DNA extraction from fresh frozen lymph node, peripheral blood or bone marrow. A t(11;14) translocation was identified in 12 (41%) of these cases (Table 1) . We chose a seminested PCR procedure for our analysis because a single step PCR evolved to be less sensitive especially in DNA extracted from paraffin fixed tissue. Optimal PCR results for the amplification of DNA extracted from fresh frozen tissue were obtained with the primer combination F (bcl-1) and J H in the first round and primer B (bcl-1) and J H in the second round. Specific PCR products were size separated on an 3% agarose gel and visualized by ethidium bromide staining and UV illumination. Representative results are shown in Figure 1 . Individual PCR products varied in size between 180 and 250 base pairs depending on the length of the respective N-region and the location of the breakpoints on chromosome 11 and 14 ( Table  2) . Interestingly a t(11;14) translocation could also be amplified in two of three patients with the anaplastic variant of MCL (cases 27-29, Table 1 ) as additional evidence for the biological relationship between variant and classical MCL. 25, 26 For the amplification of DNA extracted from paraffin embedded tissue in the series of the 36 MCL we selected a second external bcl-1 primer (primer G) that was located six bases upstream of the position of the internal primer B on the bcl-1 gene. With a one step PCR procedure we identified a bcl-1 rearrangement in only one case, whereas the seminested PCR approach identified six bcl-1/J H rearrangements by direct visualization in an ethidium bromide stained agarose gel. A ␤-actin control PCR in the 30 t(11;14)-PCR-negative cases identified five samples with DNA unsuitable for PCR, probably due to extensive degradation or other factors. So the
Figure 1
Size separation and direct visualization of t(11;14) PCR products by electrophoresis in an ethidium bromide stained 3% agarose gel. Lanes are numbered according to the patients numbers in Tables 1-3 . t(11;14) PCR positive cases are shown in 1, 6, 17, 22, 23, 24, 27, 29, P5 and P6. Cases negative for t (11;14) were loaded in lanes 3, 9, 15, 26, P7 and P11. P-no denote paraffin-derived DNA samples; N, negative control; P, t(11;14) positive cell line used as positive control; Right lanes, size standard. 
The junctional N-(D H )-region sequences with the flanking bcl-1 (chromosome 11) and J H (chromosome 14) sequences are shown. Sequences belonging to known D H -elements are underlined. Cases are numbered as in Table 1 and Figure 1 .
detection rate for a bcl-1/J H rearrangement was six out of 31 (20%) paraffin samples with intact DNA. We characterized the junctional DNA sequences by direct PCR sequencing in 16 samples to confirm the specificity of the PCR and to determine the junctional region bcl-1/J H sequences as clone-specific marker in individual patients. Furthermore sequence analysis avoided false positive PCR results due to contamination which is a common problem especially in seminested PCR procedures. The structure of the different bcl-1/J H junctions is shown in Table 2 . We identified 15 different breakpoints on chromosome 11 scattering in a range of 100 base pairs in the major translocation cluster region. In one particular case (case 2) the breakpoint was located outside the published MTC sequence further downstream on chromosome 11. Two cases (cases 17 and 27) had identical MTC and J H breakpoints but could be distinguished from each other due to their different N-regions. Sequence analysis showed a preferential use of joining region J H 4 segment in 11 out of the 16 sequences. The intervening N-regions between the breaks on bcl-1 and J H varied extensively in size (1-39 base pairs) and none of these insertions had significant homology to the others. Noteworthy in six cases (cases 6, 22-24, P4-P6) with unusually long N-regions 1-2 known D H segments could clearly be identified (Table 2) .
In three patients (P21, P28, P29) we analyzed DNA extracted from formalin fixed lymph nodes at diagnosis and at relapse from fresh frozen bone marrow aspirate and peripheral blood (P21) or paraffin-embedded lymph nodes (P28, P29). Sequencing of the respective t(11;14) PCR products revealed an identical clone at diagnosis and relapse in all cases after chemotherapy with at least four cycles of cyclophosphamide, vincristin and prednisone (COP) leading to complete (P21) or partial remission (P28, P29).
IgH-CDR3-PCR analysis and assessment of B cell clonality by gene scanning
In 60 cases we also performed IgH-CDR3 PCR for clonality assessment in addition to t(11;14) PCR. To determine the monoclonal character of the IgH-CDR3-PCR products they were size separated on a high resolution polyacrylamide gel and analyzed by automated fluorescence quantification and accurate size determination. Because of the hypervariable character of rearranged IgH-CDR3 junctions, the fluorescence intensity size-distribution pattern of a given PCR product characterizes the corresponding B cell population. Depending on the source of DNA the PCR fragments yielded a typical fluorescence peak pattern with one or two monoclonal peaks (depending on the number of rearranged IgH alleles) and relatively weak background signals from admixed polyclonal B cells. 27 From 29 patients of which high molecular weight was available, 23 patients (79%) showed a monoclonal IgH-CDR3 PCR result by gene scanning whereas from 31 samples with intact DNA extracted from paraffin only 11 (36%) were positive. The IgH-CDR3 PCR results are summarized together with the t(11;14) results in Tables 1 and 3 .
In Figure 2 , the IgH-CDR3 PCR result and respective gene scanning analysis of the PCR products from bone marrow and peripheral blood collected at initial diagnosis of a patient with the anaplastic variant of MCL is shown. In this case gene scanning displayed one prominent peak of fluorescence of identical size in the bone marrow as well as in peripheral blood with relatively weak background side bands. This patient had a bone marrow infiltration and peripheral blood involvement with a high percentage of tumor cells at diagnosis.
To demonstrate that IgH-CDR3 gene scanning is also a semiquantitative method to determine the relative amount of tumor cells in bone marrow or peripheral blood we investigated a patient with stage IV MCL (case 6), who achieved a complete clinical and morphological remission after four cycles of chemotherapy with prednimustine and prednisone (PmM). DNA extracted from bone marrow at diagnosis, peripheral blood and bone marrow during and after four cycles of chemotherapy was analyzed by IgH-CDR3 PCR. As demonstrated in Figure 3a , a strong PCR signal is obtained at diagnosis which persists but becomes almost invisible in the agarose gel during and after chemotherapy. However the sensitive and specific analysis of the respective IgH-CDR3 PCR products by gene scanning with consensus primers (Figure 3b) clearly identified the patient-specific IgH-CDR3 PCR band and also allowed the estimation of the relative 
Figure 2
Electrophoretic (agarose gel and gene scanning) profiles of IgH-CDR3 PCR products generated from bone marrow (BM) and peripheral blood (PB) derived DNA of patient 27. Products were analyzed either visually after electrophoresis in an ethidium bromide stained 3% agarose gel (a) or after PCR with fluorescent primers on a high resolution acrylamide gel by the GENESCAN 672 software on the automated sequencer (b and c). During gene scanning relative fluorescence intensities (y-axis) are plotted as a function of PCR fragment size in basepairs (x-axis). As expected, both PCR products were of identical size.
amount of tumor cells (about 1%) by measurement of the relative fluorescence intensity. This result also indicates that the CDR3 region is stable in relapsing MCL representing the malignant clone.
Allele specific IgH-CDR3 PCR
Sequencing the respective IgH-CDR3 PCR products allowed not only the confirmation of the specificity of the gene scanning results, but also the design of clone specific primers (Nprimers) for patient-specific PCR. We used these N-primers successfully in a nested PCR procedure to increase the detection limit for minimal residual lymphoma cells and for sequence-specific amplification of the respective rearrangement. An example is shown in Figure 3c (patient 6). Note that the allele-specific PCR signals are almost equally intense because the PCR was run at saturation. With the clone-specific primers the sensitivity of the PCR reaction is generally improved to a detection limit of one tumor cell in 10 
Discussion
Classical mantle cell lymphoma and its morphologic variants belong to the most critical and often misdiagnosed lymphoma entities. This is especially true when only small biopsy specimens or bone marrow samples with CD5/CD20 coexpressing lymphocytes are available for morphological analysis. Detection of the translocation t (11;14) in mantle cell lymphoma by PCR can improve the diagnosis in critical cases of MCL and may thus be included in the routine analysis of lymphoma specimens, at least in those cases where MCL has to be considered as differential diagnosis.
With our primer selection for t(11;14) PCR we detected a bcl-1 rearrangement in 41% of the cases with fresh frozen lymph node material and in 20% from paraffin-embedded tissue. Our findings are in good agreement with previous studies demonstrating that a t(11;14) translocation can be amplified by PCR from fresh frozen material with an incidence of 20-50% 6, 28, 29 and also in paraffin-embedded tissue of mantle cell lymphomas. [30] [31] [32] Since in the present study most t(11;14) PCR products were characterized by DNA sequencing, the results reported here show the highest possible degree of accuracy and reliability for PCR assays. The observed bcl-1-N-J H regions differed extensively in size (1-39 base pairs) and none of these insertions had homology to each other. Noteworthy in seven cases (cases 6, 22-24, P4-P6) analysis of the N-region sequences with respect to homology to D genes identified 1-2 known D H segments within the bcl-1/J H junctions (Table 2) . This phenomenon has already been described for bcl-2/J H junctional regions 23, 33, 34 and provides first evidence, that also bcl-1/J H rearrangements can occur not only as a mistake in D H -J H joining in the pre-B-cell stage, but also in a later stage of B cell ontogeny during which the complete V H to D H -J H joining or V H -replacement takes place. 34 This hypothesis is supported by the observation of Andersen et al 10 who found that replacement mutations occur significantly in excess in CDR1 and CDR2 regions of the rearranged IgH gene in MCL indicating that the final malignant transformation in MCL is likely to happen in a mature B cell that has been stimulated by antigen.
On chromosome 14 the breakpoints were located within the 5Ј portions of the J H segment with a preponderance of J H 4 in the recombination. This has already been described by Williams et al 6 and is also common for t(14;18) translocations and IgH-rearrangements. 21, 27, 33 With the primers used in the present study the detection of t (11;14) translocation is restricted to rearrangements involving the MTC region on chromosome 11. 6 Due to bcl-1 rearrangements outside MTC in a significant proportion of patients, a t(11;14) translocation is detected by routine PCR only in about one half of MCL carrying a t(11;14) translocation. 4, 29 However, at least from fresh material a monoclonal IgH gene rearrangement can be identified in most cases which can also be used to track MRD in MCL patients. 21, 27, 35 Our group has shown previously that efficient amplification of IgH-CDR3 rearrangement with consensus J H and V H primers is possible in different subtypes of NHL especially MCL and CLL because of the low rate of somatic mutations in the V H region of those lymphomas. 21, 27 For assessment of clonality in MCL we therefore additionally performed IgH-CDR3 PCR analysis with fluorescent dye labeled J H and V H consensus primers in all samples and obtained positive results in 79% of these cases from fresh frozen material. In four samples we found a biallelic IgH-CDR3 rearrangement by gene scanning indicating that a participation of the IgH gene in a chromosomal translocation involving chromosome band 11q13 is unlikely in these four cases. However a variant translocation of chromosome band 11q13 to other chromosomes may have occurred as has been described for B-non Hodgkin's lymphoma. 36 On the other hand, we consequently did not find a biallelic IgH-CDR3 rearrangement in patients with a demonstrated t(11;14) translocation.
For routine diagnostic procedures paraffin-embedded tissue is the main source of DNA for molecular analysis. Therefore we investigated the applicability of our assay in a series of 36 paraffin-embedded lymph node tissues of patients with MCL. We detected a bcl-1/J H rearrangement in only six out of 31 cases (20%) where DNA suitable for PCR could be extracted. This is significantly less than reported by other investigators where 30-50% of the cases were t(11;14) positive by PCR. [30] [31] [32] Taken together the assessment of clonality was possible in only 42% of the paraffin samples with the combined use of t (11;14) and IgH-CDR3 PCR (Table 3 ). In particular the results of IgH-CDR3 PCR from paraffin-derived DNA were significantly worse compared to fresh frozen material indicating that the quality of paraffin-derived DNA was very poor even in the samples yielding a ␤-actin PCR product.
Several authors demonstrated the relevance of molecular genetic detection of MRD in reinfused autologous stem cell products on relapse and survival in patients with follicular lymphomas undergoing high-dose therapy. 11, 12, 14 A recent publication by Andersen et al 10 has stressed the clinical significance of MRD detection for patients undergoing high-dose chemotherapy and autologous bone marrow transplantation for treatment of MCL.
As we have shown, PCR detection of residual lymphoma cells by t (11;14) and IgH-CDR3 PCR in bone marrow and peripheral blood is possible even in clinical and morphological complete remission and the CDR3 region is stable in MCL representing the malignant clone. Hence, detection of MRD by t (11;14) and IgH-CDR3 PCR on a routine basis may be clinically useful in MCL patients treated with autologous bone marrow or peripheral blood stem cell transplantation.
The evaluation of the IgH-CDR3 PCR products by gene scanning reveals a characteristic fluorescence-intensity sizedistribution pattern for each patient and allows the rapid and sensitive detection of monoclonal PCR products avoiding labor-intensive and time-consuming PCR cloning. 27 Sequencing of the respective PCR products allows the design of clone-specific primers for each individual breakpoint region or IgH-CDR3 rearrangement. With the use of clone-specific primers the specificity of PCR is greatly improved and the sensitivity of the PCR reaction can be increased to a detection limit of one tumor cell in 10 4 -10 5 polyclonal cells with 1 g of DNA is used for PCR. Furthermore, a quantitation of the individual PCR products is possible by serial dilution and quantitative determination of the fluorescence intensity of individual PCR products (Kneba et al, unpublished observation) . Thus a combination of t(11;14) PCR followed by IgH-CDR3 PCR in t(11;14)-negative cases is the method of choice in the search for clonality or MRD in patients with MCL undergoing high-dose chemotherapy. With the methods demonstrated by us routine follow-up of serial probes will be possible in a reliable way and quantification of MRD is facilitated by the gene scanning procedure.
